|
inhibitory C-type lectin receptor signaling pathway
|
GO_0002772 |
[A series of molecular signals initiated by the binding of an extracellular ligand to an inhibitory C-type lectin receptor capable of inhibiting an immune effector process contributing to an immune response.] |
|
SAA1
|
OGG_3000006288 |
|
|
travel history item
|
GENEPIO_0000120 |
[A datetime measurement related to a person's travel with respect to potential epidemilogical implications.] |
|
endosome membrane
|
GO_0010008 |
[The lipid bilayer surrounding an endosome.] |
|
S100A9
|
OGG_3000006280 |
|
|
generically dependent continuant
|
BFO_0000031 |
[b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001])] |
|
neutrophil
|
CL_0000775 |
[Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.] |
|
process boundary
|
BFO_0000035 |
[p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001])] |
|
endoplasmic reticulum-Golgi intermediate compartment membrane
|
GO_0033116 |
[The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.] |
|
IL33
|
OGG_3000090865 |
|
|
function
|
BFO_0000034 |
|
|
combined T cell and B cell immunodeficiency
|
DOID_628 |
[A primary immunodeficiency disease that involves multiple components of the immune system, including both humoral immunity and cell-mediated immunity.] |
|
reproductive structure development
|
GO_0048608 |
[The reproductive developmental process whose specific outcome is the progression of structures that will be used in the process of creating new individuals from one or more parents, from their formation to the mature structures.] |
|
peginterferon alfa-2a
|
DRON_00016951 |
[A covalent conjugate of recombinant interferon alfa, subtype 2a, and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha-2a protein moiety. Interferons alfa bind to specific cell-surface receptors, leading to the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer and immune-modulating effects. The PEG moiety lowers the clearance of interferon alpha-2a, thereby extending the duration of its therapeutic effects, but may also reduce interferon-mediated stimulation of an immune response.] |
|
clathrin-coated pit
|
GO_0005905 |
[A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.] |
|
one-dimensional temporal region
|
BFO_0000038 |
|
|
subdivision of tube
|
UBERON_0013522 |
[Tube subdivisions that can eventually develop into distinct regions various organ systems] |
|
dolutegravir
|
CHEBI_76010 |
[A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid with the amino group of 2,4-difluorobenzylamine. Used (as its sodium salt) for treatment of HIV-1.] |
|
regulation of cell cycle G2/M phase transition
|
GO_1902749 |
[Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle.] |
|
plasma lipoprotein particle
|
GO_0034358 |
[A spherical particle with a hydrophobic core of triglycerides and/or cholesterol esters, surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Plasma lipoprotein particles transport lipids, which are non-covalently associated with the particles, in the blood or lymph.] |